Lemaitre Vascular (LMAT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Financial Fact:
Income from operations: 5.34M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $26.15 million versus the consensus estimate of $26.23 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2018 EPS of $0.19-$0.21. Lemaitre Vascular sees Q1 2018 revenue of $26-26.6 million.
Lemaitre Vascular sees FY 2018 EPS of $0.96-$1.00. Lemaitre Vascular sees FY 2018 revenue of $11.0-111.6 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lemaitre Vascular (LMAT) Misses Q3 EPS by 4c ; Offers Guidance
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Enact Holdings (ACT) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
